Specific renal histopathological findings related to cardiovascular disease risk in patients with CKD

Published Date: 10 Mar 2023

Chronic renal failure (CKD) is a risk factor for cardiovascular diseases such as heart attacks, strokes or heart failure. Brigham the scientist...

Read Full News

Latest News

Secret Shopper Study Warns About Online GLP-1 Sellers

Two-thirds of websites did not require clinician interaction before a prescription

Case Report: Cannabis and Compulsive Showering

An unexpected effect of chronic marijuana use

Chronically Short Sleep May Lead to Weight Gain in Adults With Heart Risks

Pooled analysis of two trials shows impact when losing just 1.5 hours a night

When Endurance Training Can Be Deadly for Older Athletes

This case shows the danger of one asymptomatic condition in particular

Cardiologist Runs for Mayor; PCSK9 Inhibitor Price Drops; Pregnancy OK After AVR?

Recent developments of interest in cardiovascular medicine

ASPECTS Fails to Reflect Ceiling for Endovascular Stroke Therapy Benefit

Quantitative volumetry better avoids futile reperfusion, per a nationwide study

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Latest News

Two-thirds of websites did not require clinician interaction before a prescription

An unexpected effect of chronic marijuana use

Pooled analysis of two trials shows impact when losing just 1.5 hours a night

This case shows the danger of one asymptomatic condition in particular

Recent developments of interest in cardiovascular medicine

Quantitative volumetry better avoids futile reperfusion, per a nationwide study

News All Time

From Evidence to Practice: Individualizing P2Y12 Strategies in Recurrent MI Management

From Evidence to Practice: Individualizing P2Y12 Strategies in Recurrent MI Management

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Bridging Evidence and Practice: Closing the Gap to Achieve LDL-C Targets and Reduce ASCVD Risk

Bridging Evidence and Practice: Closing the Gap to Achieve LDL-C Targets and Reduce ASCVD Risk

Advances in Recurrent MI Management: Current and Emerging P2Y12 Strategies

Advances in Recurrent MI Management: Current and Emerging P2Y12 Strategies

Changing Paradigms in Paroxysmal Nocturnal Hemoglobinuria: Understanding New Pathways, Clinical Evidence, and Practice Guidelines

Changing Paradigms in Paroxysmal Nocturnal Hemoglobinuria: Understanding New Pathways, Clinical Evidence, and Practice Guidelines

Bridging the Divide in Adult Immunization: Strategies for Vaccine Equity and Confidence

Bridging the Divide in Adult Immunization: Strategies for Vaccine Equity and Confidence

Visceral Fat and Cardiometabolic Risk Factors; Autoantibodies and IBD

Also in TTHealthWatch: insulin price caps

GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication

Real-world data found patients on GLP-1s had lower odds of osteomyelitis, ulcers, and amputation

Diabetes Tied to Higher Death Risk After Solid Organ Transplant

Mortality was worse for those with pre-existing and new-onset diabetes

Less Than 1% of Hypertension Cases Screened for Primary Aldosteronism

Real-world study turned up a "meaningful" 8.7% positive rate

FDA Clears First OTC Continuous Glucose Monitor for Kids

Authorization of Stelo integrated CGM extends to children without diabetes as well

COVID Shots Tied to Lower Risks of Heart Attack, Cardiac Death

Three studies suggest that getting a COVID vaccine is still beneficial for adults

Diabetes Patients on Semaglutide Had Fewer Fractures, Study Finds

"It would be exciting if these medications were truly bone protective," says researcher

Teplizumab Approval Expands to Early Type 1 Diabetes

Product aims to disrupt the autoimmune attack against insulin-producing beta cells

Balloon-Expandable TAVR Has Struggles Evident at 10-Year Follow-Up

Mortality linked to second-generation Sapien XT in intermediate surgical risk cohort

PAs in Cardiology; Increased Risks With Gout; Bad News for Female Heart Recipients

Recent developments of interest in cardiovascular medicine

Recommended News For You

Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals

Woman Loses 6-Year Battle With Mouth Tumor

Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy

PNH With Extravascular Hemolysis Approves Factor D Inhibitor.

Liver cancer cells under pressure: Compression can spark invasion, drug resistance and altered gene activity

The Boom in ADHD Coaching Has Few Rules

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

Recommended Articles For You

Essential Updates in Hematology in Daily Practice 

Integrative Clinical Genomics of Metastatic Cancer: Decoding Tumor Evolution for Precision Oncology 

Beating Cancer Fatigue The Most Effective Exercise Strategies for Breast Cancer Survivors 

Debunking Myths About Systemic Mastocytosis: Separating Fact from Fiction  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Best foot forward—chemo care should include podiatry, say researchers

2.

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

3.

High weight and obesity are associated with poor outcomes in leukemia treatment.

4.

Researchers discover that children who survive cancer have socioeconomic challenges.

5.

Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.

1.

The Journey Beyond Treatment: Empowering Cancer Survivorship with Technology and Artificial Intelligence

2.

Contemporary Approaches in Hematology for Specialists

3.

The Algorithmic Oncologist: A Comparative Clinical Review of AI in Predictive Cancer Planning

4.

Exploring the Potential of Cytologic Atypia in Cancer Diagnosis

5.

Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III

2.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

3.

Oropharyngeal Cancer in Relation to HPV Status

4.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases

5.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot